Hepatitis C Support Group
Hepatitis C is a blood-borne viral disease which can cause liver inflammation, fibrosis, cirrhosis and liver cancer. The hepatitis C virus (HCV) is spread by blood-to-blood contact with an infected person's blood. Many people with HCV infection have no symptoms and are unaware of the need to seek treatment. Hepatitis C infects an estimated 150-200 million people worldwide.
I mean, Sofos was going to be one of the first, but are they trying to now claim the first coveted "all oral" now too? Seems sneaky.
Gilead is trying to pull a fast one here, that's what I think. And... the FDA has bought into it? WTF?
And gee, "Gilead had provided no indication that data to support this particular labelling had been submitted to the FDA. Expectation instead was for sofosbuvir to only be approved in genotype 1 patients in combination with interferon and ribavirin." MY RED FLAG IS WAVING HERE, FOLKS!
I want NOTHING to do with this bogus tx - even IF my insurance would cover the bulk of the cost of it. Oh sure, pay for GILEAD's drug for 24 WEEKS - $168,000 (plus the Riba) instead of trying to get off-label Sovaldi + Olysio (yes, would cost as much for 12 weeks of those two BUT that combo has proven stellar in trials - this Sovaldi + Riba for Geno 1's is a bit lacking in that regard). Oh, or maybe wait for Abbvie's cocktail that should be FDA approved in the latter half of next year - with NO INTERFERON and has had great results in trials even with cirrhotic Geno 1a?
For me - forget this Gilead carrot dangling on a stick - for me, it's off-label Sovaldi/Olysio or wait for Abbvie. I won't fall for this ruse that Gilead is trying to pull off.
Something is really twisted about this, and this article laid it all out. wow
So now what is THIS? "Gilead is reportedly offering a patient support programme that will ensure that most commercially insured patients will have no more than a $5 co-pay, which will include patients who are charged larger co-insurance amounts." What the hell is "most commercially insured patients..."? "most"?
And right now I'm listening to something on tv about how the AFA is going to mean... paying MORE for drugs - much higher co-pays in a lot of cases. omg omg
Before this U.S. healthcare mess gets even worse, I am going to grab the first reasonable tx that my insurance will cover - just NOT this 24 week attempt by Gilead to grab us Geno 1s with the lure of no interferon necessary. No thank you!
(brand names Sovaldi and Virunon)
http://www.meduweb.com/showthread.php?p=35110
Gilead is pissing me off!
And - 68% or FORTY-EIGHT %, depending on riba dosage, of those in the second group (didn't say how many people - maybe 8?) achieved SVR 24? This is.... I mean, what kind of stats are these? Does this make me all excited about jumping into six MONTHS of Sovaldi and Riba? I think not.
"Following 24 weeks of treatment for all study participants, nine out of the 10 participants in the first group completed the trial and all of them (90 percent) achieved a sustained virologic response 24 weeks after completing therapy (SVR24, considered a cure). In the second group, 68 percent of those in the weight-based ribavirin subgroup achieved SVR24, while 48 percent were cured in the low-dose ribavirin arm, although this difference was not statistically significant, meaning it could have occurred by chance."
GOOD article! INFORMATION IS POWER! When I see my doc in Phoenix next month, I will ask him what he thinks about this ploy by Gilead to rope in Geno 1's NOW. He knows I will not do Interferon - no matter what. Can't wait to hear his response. If he suggests that I DO THIS - I may have to do an "about face."
I have a real sense of urgency because (1) I'm late stage and OLD and (2) I can feel the fed. govt. angling for a way to rip off military retiree benefits, and healthcare is a huge huge budgetary expense, and even pay - as it is, no cost of living adjustments of ANY value for YEARS now....
Gilead has Sofos/Led (okay SOVALDI/Led) in the hopper but .... not for a year FDA approved? Why not? I know why - they'd rather push 5816, in trials now for ALL genotypes. They don't care if some of us die off before it's FDA approved. There are lots of HCV victims out here and MANY who don't even know THEY ARE. MILLIONS and MILLIONS.
I need to take a chill pill.
(Love this thread, Kramer - it is really relevant for Geno 1s)
"The Phase II, open-label study had two parts. In the first, which was a proof-of-concept study, 10 people who had liver fibrosis that ranged from absent to moderate in severity received sofosbuvir plus weight-based ribavirin. In the second part, 50 participants who had all the various stages of liver disease were randomly and evenly divided into two groups. Both received sofosbuvir, while one received weight-based ribavirin and the other received a lower dose of 600 milligrams per day of ribavirin, irrespective of their weight."